No Data
No Data
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex, Granting Exclusive Commercialization Rights For ELADYNOS In Mexico, Canada, South Africa, Israel, And Russia, Along With Additional Unpartnered Regions; Radius To Receive...
Radius Pharmaceuticals Expands Abaloparatide Licensing Agreement With Theramex Granting Additional Commercialization Rights Including Mexico, Canada, South Africa, Israel, and Russia
With 84% Ownership of the Shares, Radius Recycling, Inc. (NASDAQ:RDUS) Is Heavily Dominated by Institutional Owners
Steel Stocks Rise as Goldman Takes Positive View; Likes Cliffs, Commercial Metals, Nucor
Radius Recycling Initiated at Neutral by Goldman Sachs
Goldman Sachs Initiates Coverage On Radius Recycling With Neutral Rating, Announces Price Target of $22